⌘K
Loading ticker…
As of 2026-08-21, TG Therapeutics, Inc. (TGTX) has a 3-month relative strength percentile of 91 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 70. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.6%, relative volume 2.51×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
TGTX is in a stage 2 uptrend, week 1. Currently in a 31-day base; basing ADR 4.4% (broad 4.4%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 2.7% / 43.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
TGTX is held by 37 ETFs as of May 2026. Top owner: VTWO at 0.16% weight, $28M notional. Top 3 carry $71M.
Held by 95 ETFs · $1.2B across latest filings · largest weight 3.15% (PBE).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.16% | $28M | +0.02 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.11% | $25M | +0.01 pp |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.30% | $18M | +0.04 pp |
| VHTVanguard Health Care ETF | 0.09% | $17M | +0.02 pp |
| VIOGVanguard S&P Small-Cap 600 Growth ETF | 0.61% | $6M | +0.10 pp |
| XSHQ | 2.25% | $5M | +0.59 pp |
| VTWG | 0.31% | $5M | +0.03 pp |
| PSCH | 2.75% | $4M | +0.31 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.01% | $3M | — |
| GSSC | 0.20% | $2M | −0.03 pp |
Showing 10 of 37 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TGTX Jan avg: 6.97% median: 2.02% win: 50% σ: 15.12% n: 4 2022-04-12 → 2026-07-31 | TGTX Feb avg: 2.10% median: 3.72% win: 75% σ: 5.05% n: 4 2022-04-12 → 2026-07-31 | TGTX Mar avg: 5.91% median: 2.14% win: 50% σ: 19.20% n: 4 2022-04-12 → 2026-07-31 | TGTX Apr avg: 9.64% median: 1.69% win: 60% σ: 34.22% n: 5 2022-04-12 → 2026-07-31 | TGTX May avg: -4.06% median: 7.25% win: 60% σ: 24.17% n: 5 2022-04-12 → 2026-07-31 | TGTX Jun avg: 9.18% median: 2.51% win: 60% σ: 20.84% n: 5 2022-04-12 → 2026-07-31 | TGTX Jul avg: 5.73% median: -1.36% win: 40% σ: 22.04% n: 5 2022-04-12 → 2026-07-31 | TGTX Aug avg: -7.22% median: 0.75% win: 50% σ: 32.92% n: 4 2022-04-12 → 2026-07-31 (current) | TGTX Sep avg: -3.60% median: -8.70% win: 25% σ: 19.83% n: 4 2022-04-12 → 2026-07-31 | TGTX Oct avg: -1.45% median: -2.71% win: 25% σ: 6.22% n: 4 2022-04-12 → 2026-07-31 | TGTX Nov avg: 37.94% median: 45.21% win: 75% σ: 30.26% n: 4 2022-04-12 → 2026-07-31 | TGTX Dec avg: 10.90% median: 11.48% win: 50% σ: 26.40% n: 4 2022-04-12 → 2026-07-31 |